Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on US Healthcare Journal.
Press releases published on March 11, 2025
The Joint Corp. Names SVP Development
GlobeNewswire
·
March 11, 2025
SCOTTSDALE, Ariz., March 11, 2025 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, welcomes Craig Sherwood as the company’s new Senior Vice President of …
Helius Medical Technologies, Inc. Announces First Reimbursement by A Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS®) Device
GlobeNewswire
·
March 11, 2025
--Anthem Blue Cross Blue Shield approves claim for PoNS Device at out-of-network adjusted list price-- --Provides further validation of PoNS pricing-- NEWTOWN, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius …
Tilray Medical Launches Tilray Craft: Introducing High THC, High Terpene Genetics to the German Medical Cannabis Market
GlobeNewswire
·
March 11, 2025
NEUMÜNSTER, Germany, March 11, 2025 (GLOBE NEWSWIRE) -- Tilray Medical (“Tilray”), a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) and a global leader in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare …
Tonix Pharmaceuticals to Present at the Zacks SCR Life Sciences Virtual Investor Forum on March 13th
GlobeNewswire
·
March 11, 2025
CHATHAM, N.J., March 11, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, today announced that Seth Lederman M.D., …
Rapport Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
GlobeNewswire
·
March 11, 2025
Results of positron emission tomography (PET) trial and second multiple ascending dose (MAD-2) trial support RAP-219's transformative potential for epilepsy and other central nervous system (CNS) disorders Continued momentum in the Phase 2a trial of RAP- …
Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors
GlobeNewswire
·
March 11, 2025
BEDMINSTER, N.J., March 11, 2025 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) today announced the appointment of biotech industry veterans Keith Murphy and Edward Neugeboren to its Board of Directors as independent members, …
Arvinas and Pfizer Announce Positive Topline Results from Phase 3 VERITAC-2 Clinical Trial
GlobeNewswire
·
March 11, 2025
– VERITAC-2 achieved its primary endpoint in the estrogen receptor 1-mutant population, demonstrating statistically significant and clinically meaningful improvement in progression-free survival – – Vepdegestrant is the first PROTAC degrader to demonstrate …
UPDATE – The Ensign Group to Present at the 35th Annual Oppenheimer Healthcare MedTech & Services Conference on March 18, 2025
GlobeNewswire
·
March 11, 2025
SAN JUAN CAPISTRANO, Calif., March 11, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and …
Over Half of UK Organisations Experienced a Security Breach Resulting from Third-Party Access in the Past Year, Imprivata Study Finds
GlobeNewswire
·
March 11, 2025
LONDON, March 11, 2025 (GLOBE NEWSWIRE) -- Imprivata, the digital identity company for life- and mission-critical industries, today released new research with the Ponemon Institute which found that 51% of UK organisations have experienced a data breach or …
ProstaVive Reviews (Consumer Report Analysis) Is It Safe And Effective For Healthy Prostate Function?
GlobeNewswire
·
March 11, 2025
TALLMADGE, Ohio, March 11, 2025 (GLOBE NEWSWIRE) -- ProstaVive is a novel prostate support supplement that has gained popularity over the past few days. According to the team that created this supplement, it contains important nutrients clinically proven …
Alpha Bites Reviews: Is It Safe And Beneficial For Men? AlphaBites Gummies Ingredients, Side Effects, And Results!
GlobeNewswire
·
March 11, 2025
LAKELAND, Fla., March 11, 2025 (GLOBE NEWSWIRE) -- Alpha Bites is an all-natural formula developed using scientifically proven ingredients to support virility and stability. It suits all men above the age of 18 and helps them attain a boost in their energy …